News Updates
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Aging Frailty: A Systematic Review
Aging frailty is a multifactorial geriatric syndrome characterized by reduced physiological reserve across multiple interrelated systems, leading to increased vulnerability to adverse health outcomes. Mesenchymal stem cells (MSCs) have emerged as a potential therapeutic intervention due to their immunomodulatory and regenerative properties. This systematic review aimed to evaluate the available clinical evidence regarding the safety and efficacy of MSC administration in individuals with aging frailty.
Source: MDPI
Cell Therapy is Reshaping the Landscape of the Orthopedics Field, As Industry Giants are Rushing to Place Bets, with Numerous Phase II/III Pipelines Clustered in this Track.
Cell therapy is expected to provide a fundamental solution to this dilemma. Mesenchymal stem cells (MSCs) are a type of adult stem cells with self-renewal and multi-directional differentiation capabilities, with low immunogenicity. Through paracrine and immunomodulatory mechanisms, they can play roles in tissue injury repair, hematopoietic support, nutritional supply, activation of endogenous stem/progenitor cells, immunoregulation, promotion of angiogenesis, and anti-fibrosis.
Source: European Central Station
Responders vs. Non-Responders to Mesenchymal Stromal Cells in Knee Osteoarthritis: Mechanistic Correlates of Donor Cell and Patient Features
Mesenchymal stromal cell (MSC) injection has afforded heterogeneous outcomes in knee osteoarthritis (KOA). Herein, a framework that dually correlates KOA patient responsiveness with baseline autologous bone marrow-derived MSC(M) donor batch attributes and baseline clinical and biomarker features is provided. Using clinical trial data (NCT02351011), we demonstrated that MSC(M) with increased immunomodulatory potency are more efficacious. Multivariable MSC(M) genes correlated strongly with responder status and 12- and 24-month improvements in Knee Injury and Osteoarthritis Outcome Scores.
Source: Stem Cell Reports
Stem Cells in Orthopedic Rheumatology: Where Clinical Signals Are Strongest
Stem-cell therapies in orthopedic rheumatology offer dual promise: immunomodulation and tissue repair. This editorial reviews 2023-2025 evidence across key rheumatic diseases, identifying where clinical signals are strongest. Mesenchymal stromal/stem cells (MSCs) show encouraging immunologic and symptomatic benefits in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), particularly lupus nephritis, with acceptable short-term safety. However, trial heterogeneity in MSC source, dose, and manufacturing limits reproducibility.
Source: ResearchGate
Current and Emerging Therapies for Knee Osteoarthritis: From Conventional Approaches to Machine Learning and Stem Cell Innovations
Osteoarthritis is characterized by cartilage degradation and joint distortion. The most prevalent version of osteoarthritis, knee osteoarthritis (KOA), affects millions, acting as a leading cause of disability. With the average life expectancy continuing to grow, the global burden of KOA is expected to increase. KOA involves chronic pain that limits function and adversely impacts patients’ quality of life.
Source: ScienceDirect
Application of Stem Cells in Degenerative Orthopedic Diseases
Degenerative orthopedic diseases, traditionally viewed as inevitable “wear-and-tear” processes, are now being reimagined as dynamic failures of tissue homeostasis orchestrated by a complex interplay of chronic inflammation and metabolic exhaustion.
Source: Frontiers
Current Status and Future Prospects of Functionalized Mesenchymal Stem Cells for the Treatment of Spinal Cord Injury
Spinal cord injury (SCI) represents a critical neurological disorder characterized by intricate pathophysiological processes. The hostile local environment induced by secondary damage markedly hinders intrinsic neural repair, and currently available therapies exhibit limited clinical effectiveness. Recently, mesenchymal stem cells (MSCs) have attracted considerable attention due to their paracrine-mediated therapeutic properties, including immunoregulatory effects, neurotrophic factor secretion, and promotion of angiogenesis.
Source: ScienceDirect
